Impact of Physical Exercise on Lymphedema Related to Breast Cancer: Assessment Using Thermography
2 other identifiers
interventional
9
1 country
1
Brief Summary
Study Type: Clinical Trial Primary Purpose: To determine whether physical exercise improves or prevents lymphedema in breast cancer patients. Description of the Participant Population/Main Condition: The study is aimed at women who have been diagnosed with breast cancer and have experienced post-treatment lymphedema or are at risk of developing it. The target population includes adults aged 18 to 70 who have been diagnosed with this condition following their breast cancer treatment. Main Research Questions: Does physical exercise improve or prevent lymphedema in women with breast cancer? What are the effects of physical exercise on the reduction of arm volume affected by lymphedema? What are the effects of physical exercise on the reduction of perceived disability in the arm affected by lymphedema? Hypothesis: Physical exercise intervention significantly reduces lymphedema symptoms, such as arm volume. Physical exercise prevents the progression of lymphedema in women with breast cancer. Comparison Group: Researchers will compare results between the experimental group (which will undergo physical exercise) and the control group (which will receive no intervention) to determine if physical exercise has a significant impact on the improvement or prevention of lymphedema. Participant Tasks: The experimental group will follow a supervised physical exercise program for a specific period. The control group will receive no intervention and will be monitored with standard follow-up care without exercise. Participants will be evaluated before and after the study period to measure the progression of lymphedema, including arm volume measurement and surface skin temperature using thermography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2025
CompletedFirst Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 1, 2025
CompletedApril 1, 2025
March 1, 2025
1 month
March 12, 2025
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Perimeters
The perimeter of the arm affected by lymphedema will be measured to assess the reduction in lymphedema volume in the participants. This measurement will be taken before and after the intervention to compare changes and determine the impact of physical exercise on inflammation and the size of the affected arm
10 weeks
Thermography
Thermography will be used to assess the temperature distribution in the arm affected by lymphedema. A thermal image will be taken before and after the intervention to observe changes in inflammation and circulation in the affected area, allowing the evaluation of whether physical exercise has an effect on the reduction of temperature associated with lymphedema
10 weeks
Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire
The Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire will be used to assess the functionality of the arm in the participants. This questionnaire measures limitations in daily activities related to the arm affected by lymphedema. It will be administered before and after the intervention to assess changes in mobility and functional capacity following physical exercise. In the DASH questionnaire, higher scores indicate greater disability, while lower scores indicate less disability
10 weeks
Secondary Outcomes (7)
Bicipital and Tricipital Skinfolds
10 weeks
RS-14 Questionnaire (Resilience Scale for Adults)
10 weeks
Trait Meta-Mood Scale (TMMS-24)
10 weeks
MOS Social Support Survey (MOS-SSS)
10 weeks
Anthropometric measurements
10 weeks
- +2 more secondary outcomes
Study Arms (2)
INTERVENTION GROUP
EXPERIMENTALThis arm of the study consists of participants who will receive a supervised physical exercise intervention specifically designed to improve post-breast cancer lymphedema. The program includes a combination of strength exercises and aerobic exercises, aimed at improving mobility, reducing injury, and increasing muscle strength in the arm affected by lymphedema
CONTROL GROUP
NO INTERVENTIONThis arm of the study includes participants who will not receive any exercise intervention. They will continue with their usual daily routine and will be monitored throughout the study to compare changes in lymphedema between the intervention group and the control group
Interventions
A supervised physical exercise intervention was carried out, specifically designed to improve post-breast cancer lymphedema. The program will include a combination of strength exercises and aerobic exercises, with the aim of improving mobility, reducing inflammation, and increasing muscle strength in the arm affected by lymphedema
Eligibility Criteria
You may qualify if:
- Women over 18 years old diagnosed with breast cancer.
- Residing in the province of León.
- Not currently undergoing any physical exercise intervention at the time of the study.
- Not participating in lifestyle modification programs at the time of the study.
- Not presenting any relative or absolute sequelae from chemotherapy treatment that would pose a relative or absolute contraindication to their participation in this intervention (e.g., cardiological sequelae).
- Having signed the informed consent to participate in the study.
You may not qualify if:
- Presenting physical and/or psychological limitations that would hinder understanding or the ability to carry out the established intervention program.
- Presenting an infection in the upper limbs or lymphangitis.
- Fluid accumulation in the breast area requiring drainage at the time of the intervention.
- Not having signed the informed consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Marta Arias Crespolead
- University of Leoncollaborator
Study Sites (1)
Universidad de León
Ponferrada, León, 24400, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Graduate in nursing
Study Record Dates
First Submitted
March 12, 2025
First Posted
April 1, 2025
Study Start
November 4, 2024
Primary Completion
December 13, 2024
Study Completion
January 13, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share